Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21 - Bezjak,A.; Tu,D.; Seymour,L. (J Clin Oncol, 2006)